METTL3 and cancer: In contrary to the studies listed above that supported the oncogenic role of METTL3 in CRC, Ru et al. showed an antitumor role of METTL3, whose expression was associated with better survival and suppressed cancer growth and metastasis via p38/ERK pathways 46.